Cardiology M&A Advisory
For invasive, non-invasive, and integrated cardiology practices. PE platform consolidation in cardiology has accelerated dramatically since 2021, with multiple well-capitalized platforms actively acquiring groups with the right service mix and physician profile.
Speak with an advisor: (800) 815-0590How We Help Cardiology Sellers
Capital Partners' M&A framework is built around the specific dynamics of middle-market specialty practice transactions. The three engagement profiles below cover most of how cardiology practice owners come to us.
Practices with established cath lab volume, interventional procedures, and structural heart capabilities command particular buyer interest. The procedural revenue base and physician roster strength drive valuation.
Discuss your practice →General cardiology groups with five-plus physicians, ancillary services, and consistent procedural volume. The institutional buyer profile is well-suited to the middle-market segment of cardiology consolidation.
Discuss your platform →Cardiology practices integrated with vascular services, imaging (echo, nuclear, MRA, cardiac CT), and lab services achieve meaningful valuation premiums through the diversified revenue base.
Discuss your group →Market Context
Cardiology has emerged as one of the most active specialties for institutional consolidation. Major PE-backed platforms including US Heart & Vascular, Cardiovascular Associates of America, Cardiology Partners, Patrick Cardiology, and several regional rollups actively pursue acquisitions. Hospital systems remain active strategic buyers, particularly for groups with established referral networks.
The Capital Partners Approach
Multiple cardiology platforms are actively building out their geographic and clinical footprint. The competitive dynamics mean groups that run a deliberate institutional process consistently achieve materially better terms than those who engage a single buyer first. The right buyer-fit also matters beyond the headline number, given the long-term equity participation that defines most platform sales.
Cardiology transactions involve nuanced consideration of physician compensation post-close, governance, and clinical autonomy. These structural terms can be as important as the headline valuation for the partners staying with the platform.
Valuation Drivers
Cardiology practice valuation is driven by a specific set of operational, clinical, and structural factors. Below are the elements buyers evaluate most carefully when developing valuation and offer terms.
Cath lab volume, interventional procedures, structural heart, and electrophysiology case counts all factor heavily into buyer evaluation. Procedural depth is a primary valuation driver.
Ownership of cardiac catheterization labs and outpatient ASC capabilities drives meaningful multiple expansion. Buyers value the integrated facility revenue alongside professional fees.
Sub-specialty depth across interventional, electrophysiology, heart failure, and structural heart influences buyer interest. Physician tenure and post-close commitments matter.
Echocardiography, nuclear cardiology, cardiac MRI/CT, and vascular services contribute substantial value. The diversified revenue base is attractive to institutional buyers.
Commercial payer relationships, Medicare exposure, and value-based care participation all influence valuation. Risk-sharing arrangements with payers are increasingly relevant.
Independent groups vs. hospital-affiliated groups have different M&A trajectories. Hospital affiliation may restrict buyer pool but can also create strategic acquisition interest from the affiliated system.
Begin a Conversation
The most useful next step is a confidential conversation. We'll listen to your situation, give you a directional view of where your practice sits in the current market, and explain how a Capital Partners engagement would actually run. Every conversation begins under NDA.
(800) 815-0590